KEAP1 and cancer: Previous studies showed that TRIM21 may augment oxidative stress through the p62‐KEAP1‐NRF2 pathway.[45, 46, 50] However, knockout of TRIM21 did not affect NRF2 expression in RSL3‐treated cancer cells (Figure 8G).